vs

Side-by-side financial comparison of MARCHEX INC (MCHX) and SS Innovations International, Inc. (SSII). Click either name above to swap in a different company.

SS Innovations International, Inc. is the larger business by last-quarter revenue ($14.5M vs $10.8M, roughly 1.3× MARCHEX INC). SS Innovations International, Inc. runs the higher net margin — -17.0% vs -21.4%, a 4.4% gap on every dollar of revenue. On growth, SS Innovations International, Inc. posted the faster year-over-year revenue change (79.1% vs -9.0%). Over the past eight quarters, SS Innovations International, Inc.'s revenue compounded faster (99.9% CAGR vs -3.2%).

Marchex Inc. is a U.S.-headquartered technology company focused on conversational analytics, call tracking, and digital marketing solutions for small and medium-sized businesses as well as enterprise clients across North America. Its core products help businesses optimize customer acquisition strategies, quantify marketing campaign performance, and improve customer engagement across voice and digital communication channels.

SS Innovations International, Inc. is a global medical technology enterprise specializing in the research, development and manufacturing of innovative surgical robotic systems. It provides high-precision, accessible robotic platforms for minimally invasive surgery, catering to healthcare facilities across multiple regions to boost surgical outcomes and cut procedural burdens.

MCHX vs SSII — Head-to-Head

Bigger by revenue
SSII
SSII
1.3× larger
SSII
$14.5M
$10.8M
MCHX
Growing faster (revenue YoY)
SSII
SSII
+88.1% gap
SSII
79.1%
-9.0%
MCHX
Higher net margin
SSII
SSII
4.4% more per $
SSII
-17.0%
-21.4%
MCHX
Faster 2-yr revenue CAGR
SSII
SSII
Annualised
SSII
99.9%
-3.2%
MCHX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MCHX
MCHX
SSII
SSII
Revenue
$10.8M
$14.5M
Net Profit
$-2.3M
$-2.5M
Gross Margin
61.6%
43.9%
Operating Margin
-21.9%
-3.7%
Net Margin
-21.4%
-17.0%
Revenue YoY
-9.0%
79.1%
Net Profit YoY
-21.3%
-28.5%
EPS (diluted)
$-0.05
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MCHX
MCHX
SSII
SSII
Q4 25
$10.8M
$14.5M
Q3 25
$11.5M
$12.8M
Q2 25
$11.7M
$10.0M
Q1 25
$11.4M
$5.1M
Q4 24
$11.9M
$8.1M
Q3 24
$12.6M
$4.4M
Q2 24
$12.1M
$4.5M
Q1 24
$11.6M
$3.6M
Net Profit
MCHX
MCHX
SSII
SSII
Q4 25
$-2.3M
$-2.5M
Q3 25
$-1.0M
$-3.7M
Q2 25
$84.0K
$-256.7K
Q1 25
$-2.0M
$-5.7M
Q4 24
$-1.9M
$-1.9M
Q3 24
$-831.0K
$-3.2M
Q2 24
$-756.0K
$-4.1M
Q1 24
$-1.4M
$-9.8M
Gross Margin
MCHX
MCHX
SSII
SSII
Q4 25
61.6%
43.9%
Q3 25
63.1%
48.1%
Q2 25
65.1%
59.1%
Q1 25
63.3%
21.2%
Q4 24
63.2%
48.9%
Q3 24
66.4%
52.8%
Q2 24
65.6%
31.9%
Q1 24
61.9%
20.0%
Operating Margin
MCHX
MCHX
SSII
SSII
Q4 25
-21.9%
-3.7%
Q3 25
-8.2%
-14.3%
Q2 25
-4.6%
1.0%
Q1 25
-16.4%
-115.6%
Q4 24
-13.3%
-22.7%
Q3 24
-6.6%
-73.1%
Q2 24
-6.0%
-90.9%
Q1 24
-11.3%
-270.3%
Net Margin
MCHX
MCHX
SSII
SSII
Q4 25
-21.4%
-17.0%
Q3 25
-8.9%
-29.0%
Q2 25
0.7%
-2.6%
Q1 25
-17.4%
-111.0%
Q4 24
-16.0%
-23.7%
Q3 24
-6.6%
-74.0%
Q2 24
-6.3%
-91.8%
Q1 24
-12.5%
-270.5%
EPS (diluted)
MCHX
MCHX
SSII
SSII
Q4 25
$-0.05
$-0.01
Q3 25
$-0.02
$-0.02
Q2 25
$0.00
$0.00
Q1 25
$-0.05
$-0.03
Q4 24
$-0.04
$-0.01
Q3 24
$-0.02
$-0.02
Q2 24
$-0.02
$-0.02
Q1 24
$-0.03
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MCHX
MCHX
SSII
SSII
Cash + ST InvestmentsLiquidity on hand
$9.9M
$3.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$30.1M
$38.2M
Total Assets
$39.7M
$74.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MCHX
MCHX
SSII
SSII
Q4 25
$9.9M
$3.2M
Q3 25
$10.3M
$5.7M
Q2 25
$10.5M
$11.4M
Q1 25
$10.0M
$15.9M
Q4 24
$12.8M
$466.5K
Q3 24
$12.1M
$220.4K
Q2 24
$12.0M
$608.2K
Q1 24
$12.0M
$948.1K
Stockholders' Equity
MCHX
MCHX
SSII
SSII
Q4 25
$30.1M
$38.2M
Q3 25
$31.9M
$39.6M
Q2 25
$32.0M
$42.0M
Q1 25
$31.4M
$40.6M
Q4 24
$32.6M
$13.5M
Q3 24
$34.1M
$13.7M
Q2 24
$34.5M
$14.8M
Q1 24
$34.9M
$16.7M
Total Assets
MCHX
MCHX
SSII
SSII
Q4 25
$39.7M
$74.2M
Q3 25
$41.1M
$69.6M
Q2 25
$42.0M
$70.0M
Q1 25
$40.6M
$63.5M
Q4 24
$43.2M
$42.4M
Q3 24
$44.1M
$39.0M
Q2 24
$45.5M
$35.7M
Q1 24
$45.6M
$35.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MCHX
MCHX
SSII
SSII
Operating Cash FlowLast quarter
$121.0K
$-1.5M
Free Cash FlowOCF − Capex
$-3.2M
FCF MarginFCF / Revenue
-22.3%
Capex IntensityCapex / Revenue
11.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-22.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MCHX
MCHX
SSII
SSII
Q4 25
$121.0K
$-1.5M
Q3 25
$290.0K
$-7.5M
Q2 25
$803.0K
$-3.5M
Q1 25
$-2.6M
$-6.1M
Q4 24
$875.0K
$-3.3M
Q3 24
$382.0K
$-2.5M
Q2 24
$117.0K
$-1.0M
Q1 24
$-2.5M
$-2.7M
Free Cash Flow
MCHX
MCHX
SSII
SSII
Q4 25
$-3.2M
Q3 25
$-8.2M
Q2 25
$-3.8M
Q1 25
$-7.0M
Q4 24
$757.0K
$-3.4M
Q3 24
$199.0K
$-4.2M
Q2 24
$40.0K
$-3.1M
Q1 24
$-2.5M
$-2.8M
FCF Margin
MCHX
MCHX
SSII
SSII
Q4 25
-22.3%
Q3 25
-64.1%
Q2 25
-37.7%
Q1 25
-136.2%
Q4 24
6.3%
-41.7%
Q3 24
1.6%
-96.9%
Q2 24
0.3%
-69.5%
Q1 24
-21.4%
-76.9%
Capex Intensity
MCHX
MCHX
SSII
SSII
Q4 25
11.8%
Q3 25
0.0%
5.9%
Q2 25
3.2%
Q1 25
17.0%
Q4 24
1.0%
1.5%
Q3 24
1.5%
38.8%
Q2 24
0.6%
46.8%
Q1 24
0.0%
3.5%
Cash Conversion
MCHX
MCHX
SSII
SSII
Q4 25
Q3 25
Q2 25
9.56×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MCHX
MCHX

Segment breakdown not available.

SSII
SSII

System Sales$13.4M92%
Other$1.2M8%

Related Comparisons